Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Rifai, M. A. Articles by Short, D. D. Search for Related Content PubMed Citation Articles by Rifai, M. A. Articles by Short, D. D. Primary Care Veterans Access to Services Other Health Services Issues Addictive Disorders (General) Alcohol

Hepatitis C Treatment Eligibility and Outcomes Among Patients With Psychiatric Illness

OBJECTIVE: This study characterized the utilization and outcomes of hepatitis C virus (HCV) treatment among patients with psychiatric illness. METHODS: HCV treatment evaluations were tracked among 360 patients with HCV infection and psychiatric illness (substance use disorders, anxiety disorders, affective disorders, or psychotic disorders). RESULTS: Two-thirds of patients did not receive HCV treatment, 11 percent of patients died during the study period, and 42 percent were excluded from HCV treatment because of nonadherence to the evaluation process or diagnoses of psychiatric and substance use disorders. Interferon- and ribavirin treatment resulted in viral clearance in 10 percent of patients. CONCLUSIONS: A majority of patients with HCV and psychiatric illness did not receive HCV treatment, and HCV infection was associated with significant mortality. Study results highlight the need to develop innovative approaches to engage such patients in HCV treatment and to successfully manage psychiatric illness during HCV treatment.

This article has been cited by other articles:

				A. J. Mitchell, D. Malone, and C. C. Doebbeling Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies The British Journal of Psychiatry, June 1, 2009; 194(6): 491 - 499. [Abstract] [Full Text] [PDF]

				W. A. Zule, E. C. Costenbader, C. M. Coomes, and W. M. Wechsberg Effects of a Hepatitis C Virus Educational Intervention or a Motivational Intervention on Alcohol Use, Injection Drug Use, and Sexual Risk Behaviors Among Injection Drug Users Am J Public Health, April 1, 2009; 99(S1): S180 - S186. [Abstract] [Full Text] [PDF]

				E. Dieperink, J. Leskela, M. E. Dieperink, B. Evans, P. Thuras, and S. B. Ho The Effect of Pegylated Interferon-{alpha}2b and Ribavirin on Posttraumatic Stress Disorder Symptoms Psychosomatics, May 1, 2008; 49(3): 225 - 229. [Abstract] [Full Text] [PDF]

				O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort Psychosomatics, October 1, 2007; 48(5): 405 - 411. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us